Skip to content

Study Evaluating the Relevance and Reliability of Gastrointestinal Temperature Measurements From a New Device (E-celsius)

Phase 1 Study Evaluating the Relevance and Reliability of Gastrointestinal Temperature Measurements From a New Device (E-celsius)

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02910479
Acronym
e-TEMP
Enrollment
22
Registered
2016-09-22
Start date
2015-11-01
Completion date
2016-03-01
Last updated
2026-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Keywords

Body Temperature, Thermometers

Brief summary

E-Celsius device used for measuring the gastrointestinal temperature is composed of an ingestible capsule measuring the temperature as well as a transportable module receiving data from the capsule. This device allows to measure the body temperature (± 0.2 ° C) during transit of the pill in the digestive tract to a maximum sampling frequency of 30 seconds. The main risks related to such devices are related to biocompatibility (in materials used for the capsule shell, or level of contamination of the gastrointestinal environment due to a defect in the plastic envelope the pill or a lack of hygiene, previously tested in clinical trials; see section 10.2). It will compare conventional methods of estimating the central temperature continuously with gastrointestinal data obtained from the e-Celsius device. The main objective of the research is to validate the extent of gastrointestinal temperature obtained from the device under test consists of an ingestible electronic capsule and a data reception monitor. Secondary objectives will be pursued: * Assess the effects of ingestion of cold drinks on temperature readings taken via e-device Celsius, esophageal probe and a rectal probe. * Explore the thermal homogeneity of the digestive tract. * Evaluate the internal memory of the capsule and its data forwarding capacity. This protocol will also measure the reliability of the measurement system while comparing it to the standards used by health staff today.

Interventions

DEVICEE-Celsius thermometer

comparison of temperature between e-celsius and thermometer, rectal thermometer, esophageal thermometer, vital sense capsule thermometer

DEVICERectal thermometer
DEVICEEsophageal thermometer
DEVICEVital sense capsule thermometer

Sponsors

University Hospital, Caen
Lead SponsorOTHER
Institut National de la Santé Et de la Recherche Médicale, France
CollaboratorOTHER_GOV
La Région Basse-Normandie
CollaboratorOTHER
Université de Caen Normandie
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 59 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteers male or female (18 to 59 years inclusive) * Signed the informed consent. * Affiliated to the social security scheme * French speaker

Exclusion criteria

* Subject having started or stopped during the 15 days preceding the inclusion visit one of the following treatments: antidepressants, anxiolytics, antiparkinsonian agents, neuroleptics. * Subject having taken over the previous 7 days a drug to treat irritable bowel syndrome (antispasmodic, etc ...) or constipation (laxative) * Subject with known food allergies * Subject undergoing surgery for colon surgery * Subject with an organic occlusion * Subject with known abnormal liver or renal function * Subject participating in another clinical study within a month before the inclusion visit. * A person with a bodyweight under 40 kg * Any person with obstruction (known or suspected) of the gastrointestinal tract, including people with diverticula (folds) intestinal or intestinal inflammation known. * People with a BMI greater than or equal to 30. * People under guardianship * People who have or had known swallowing disorders * People who have to undergo an MRI or to be subjected to a strong magnetic field programmed during the transit of the capsule * Persons equipped with a pacemaker * People with diabetes or with diabetic history * People with heave * The detainees * Pregnant women * People with nasal septum deviation * People with against-indications to the placement of an esophageal tube: people who carry chronic esophageal pathology (eg, gastroesophageal reflux treated, hiatal hernia,)

Design outcomes

Primary

MeasureTime frameDescription
body temperaturefrom baseline to 36 hours every minutecomparisons between device e-Celsius, esophageal probe and a rectal probe

Secondary

MeasureTime frameDescription
body temperature during ingestion of cold drinksbaselineAssess the effects of ingestion of cold drinks on temperature readings taken via e-device Celsius, esophageal probe and a rectal probe
temperature of the digestive tractfrom baseline to 36 hours every minuteExplore the thermal homogeneity of the digestive tract
number of lost datafrom baseline to 36 hours every minuteThe capacity of the for each measurements method to store temperature data in the internal memory and send it to the receiver when the it is in the receiving area.
reliability of measurementsfrom baseline to 36 hours every minutereliability of the measurement system while comparing it to the standards used by health staff today

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026